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Abstract: Previous work in intact awake and sleeping goats has found that
unilateral blockade of excitatory inputs in the ventral respiratory column
(VRC) elicits changes in the concentrations of multiple neurochemicals,
including serotonin (5-HT), substance P, glycine, and GABA, while increasing
or having no effect on breathing. These findings are consistent with the
concept of interdependence between neuromodulators, whereby attenuation
of one modulator elicits compensatory changes in other modulators to
maintain breathing. Because there is a large degree of redundancy and
multiplicity of excitatory inputs to the VRC, we herein tested the hypothesis
that combined unilateral blockade of muscarinic acetylcholine (mACh),
neurokinin-1 (NK1, the receptor for substance P), and 5-HT2A receptors would
elicit changes in multiple neurochemicals, but would not change breathing.
We unilaterally reverse-dialyzed a cocktail of antagonists targeting these
receptors into the VRC of intact adult goats. Breathing was continuously
monitored while effluent fluid from dialysis was collected for quantification of
neurochemicals. We found that neither double blockade of mACh and NK1
receptors, nor triple blockade of mACh, NK1, and 5-HT2A receptors
significantly affected breathing (P ≥ 0.05) in goats that were awake or in nonrapid eye movement (NREM) sleep. However, both double and triple blockade
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increased the effluent concentration of substance P (P < 0.001) and
decreased GABA concentrations. These findings support our hypothesis and,
together with past data, suggest that both in wakefulness and NREM sleep,
multiple neuromodulator systems collaborate to stabilize breathing when a
deficit in one or multiple excitatory neuromodulators exists.
Keywords: neuromodulation, muscarinic receptor, neurokinin-1 receptor, 5HT2A receptor

The control of breathing is dependent upon the balance of
excitatory and inhibitory neuromodulators acting on their respective
receptors at multiple sites in the brainstem.10,40 Currently, the
mechanisms underlying the orchestrated release of multiple
neuromodulators, and whether or how each modulator can affect the
release of other neurochemicals, are not fully understood. These topics
continue to be of fundamental biological and clinical interest.
Acetylcholine (ACh), substance P (SP), and serotonin (5-HT) are
neurochemicals previously shown to have excitatory effects on the
central control of breathing in multiple models utilizing reduced
preparations and whole animals.3,5,11,16,17,28,32,34,35,42,46 For example, in
brainstem slices containing the pre-Bötzinger Complex (preBötC), a
site critical for the generation of inspiratory rhythm,36 application of
exogenous ACh or the cholinergic agonists carbachol and muscarine
depolarizes inspiratory neurons, induces a long-lasting inward current,
and increases respiratory frequency.34 These effects were blocked by
atropine (ATR), a nonselective muscarinic ACh (mACh) receptor
antagonist.34 Likewise, the importance of SP neuromodulation has
been demonstrated in rats and goats, wherein neurons expressing the
neurokinin-1 receptor (an SP receptor) were selectively
destroyed,16,28,46 resulting in abnormal breathing patterns and a
reduced ventilatory CO2 chemoreflex. Additionally, work in slice
preparations has shown that co-localized 5-HT and SP, presumably
from the raphé nucleus, provide tonic excitation to preBötC neurons
via 5-HT2 receptors and NK1 receptors, respectively.11,32 In agreement
with this evidence, elimination of central serotonergic neurons (and
thus all co-expressed neuropeptides) results in severe apnea,
hypoventilation, and high mortality rates in transgenic neonatal
mice,17 presumably in part through reduced neuromodulation in the
respiratory network.
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Despite a large body of work demonstrating the importance of
ACh, 5-HT, and SP as sources of excitation for respiratory output,
studies in our laboratory on intact goats while they were awake and
during sleep have found that unilateral dialysis of antagonists of mACh
receptors or NK1 receptors in the ventral respiratory column (VRC)
either increase or do not change breathing.25–27 However, in these
studies, we found that receptor antagonism alters the concentration of
one or more neuromodulators in the effluent mock cerebrospinal fluid
(mCSF). Compensation can be defined as a means of counteracting
variation or neutralizing the effect of variations. Thus we hypothesize
that these alterations in neurochemical levels likely compensated for
the disruption in excitatory transmission in the VRC during receptor
blockade, thereby preventing a decrease in breathing. These data
support the concept of interdependence among neuromodulators,
whereby attenuation of one source of excitation may be compensated
for by other modulator systems to preserve a normal level of
breathing. Therefore, in awake and sleep states, breathing may
decrease only with attenuation of multiple (rather than individual)
receptor types.
Herein, we first sought to determine the effects on breathing
and effluent neurochemical concentrations of blockade of 5-HT2A
receptors with the highly selective antagonist MDL 11939 (MDL) in the
VRC of adult goats. On the basis of previous findings with unilateral
dialysis of mACh receptor and NK1 receptor antagonists,25–27 we
believed that a logical next step would be to further explore the
concept of neuromodulator interdependence by testing the hypothesis
that unilateral double blockade of mACh and NK1 receptors, or triple
blockade of receptors of mACh, NK1, and 5-HT2A would not alter
breathing, but would elicit compensatory changes in multiple
neurochemicals. We also tested the hypothesis that there would be
sleep state-dependent effects on breathing of dialysis of a triple
cocktail of antagonists; thus these studies were also conducted at
night while goats were awake and during natural non-rapid eye
movement (NREM) sleep.
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Materials And Methods
Goats.
All animals studied herein (n = 13) were adult, nonpregnant,
female goats with an average weight of 43.1 ± 2.5 kg. Animals were
housed and studied in an environmental chamber with a 12:12-h lightdark cycle (lights-on at 6:00 A.M.). Goats were permitted ad libitum
access to food and water, except during a 24-h fasting period
immediately before all surgeries. Animals were acclimated to the
environment for ≥3 days before any procedures were initiated. All
aspects of the studies reported herein were reviewed and approved by
the Medical College of Wisconsin's Institutional Animal Care and Use
Committee before commencing any procedures or protocols.

Surgical procedures.
Before all surgeries, goats were anesthetized with ketamine (5.0
ml, 100 mg/ml, iv), intubated, and mechanically ventilated (2%
isoflurane in a background of 100% oxygen). Flunixin meglumine (1
mg/kg, im), a nonsteroidal anti-inflammatory analgesic, was given
once perioperatively. Throughout each surgery and immediately
thereafter, rectal body temperature (Tr), heart rate, blood oxygen
saturation, and respiratory rate were recorded at regular intervals.
Ceftiofur sodium (4 mg/kg, im) was administered daily and all surgical
sites were treated daily with triple antibiotic for ≥7 days after surgery.
Buprenorphine hydrochloride (0.005 mg/kg, im) was given twice daily
for 2 days postoperatively to alleviate pain. All surgeries were
performed under sterile conditions.
Electroencephalographic (EEG) and electrooculographic (EOG)
electrodes were implanted in the midline cranium and superior orbital
ridge, respectively, for monitoring and scoring sleep state. Goats were
allowed to recover for ≥14 days after instrumentation with EEG and
EOG electrodes before undergoing craniotomy, in which stainless steel
microtubules (MTs, 70.0 mm length, 1.27 mm OD, 0.84 mm ID) were
chronically implanted (unilaterally or bilaterally) into medullary tissue
targeting the preBötC. During these procedures, after an occipital
craniotomy was created, the dura mater was excised, and the
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posterior cerebellum and dorsal medulla were exposed to visualize
obex, which served as a physical landmark for implantation of MTs. As
determined in previous studies,20,47 the goat preBötC is approximately
2.5–3.5 mm rostral from obex, 4.0–5.0 mm lateral to midline, and
4.0–6.0 mm from the dorsal surface of the medulla (ventral to nucleus
ambiguus). To avoid rupturing blood vessels on the medullary surface,
the actual site of implantation in some goats was adjusted. MTs were
permanently secured with dental acrylic. Stylets of the same length as
the MTs were inserted into the MTs such that they did not protrude
into or disrupt medullary tissue. The skin was then sutured closed and
treated with triple antibiotic.

Physiological variables.
Animals were trained to become accustomed to all equipment
and study protocols. To measure respiratory parameters, a custommade plastic mask with a one-way breathing valve was secured to the
goat's snout. Inspiratory and expiratory tubing were attached to either
side of the valve. A pneumotachograph, attached in series to the
inspiratory side of the breathing valve, was used to measure
inspiratory flow (or minute ventilation, VI, liters/min), breathing
frequency (breaths/min), and tidal volume (VT, liters/breath).
Ventilatory parameters were continuously recorded on a Windaq data
acquisition system for later offline analysis. For accurate calculation of
ventilation and for assurance that the goats were in good health, a
thermocouple was inserted into the rectum to record Tr at regular
intervals throughout all studies. Tr remained within normal range
(38.5–39.9°C) for the vast majority of studies. For night studies, data
were collected in an identical manner, except EEG and EOG cables
were connected to the animal's head to monitor sleep state.

In vivo dialysis.
A dialysis probe (70.0 mm shaft, 2.0 mm membrane, 0.5 mm
membrane diameter, 20 kDa cutoff, 3 μl internal volume; Harvard
Apparatus, Holliston, MA) was inserted unilaterally into one MT. The
dimensions of the probe allowed only the membrane tip to penetrate
the tissue. The vehicle solution for all studies was mCSF (in mM: 124
NaCl, 2.0 KCl, 2.0 MgCl2, 1.3 K2PO4, 2.0 CaCl2, 11 glucose, and 26
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NaHCO3−, pH 7.32, in sterile distilled water) alone or with 1.25%
DMSO (vol/vol), as appropriate. All antagonists were dissolved in
mCSF or mCSF with DMSO. Solutions were warmed in a tonometer to
39°C and equilibrated with 6.4% carbon dioxide and 21% oxygen
(nitrogen-balanced) before being loaded into a syringe and attached to
a syringe pump (Harvard Apparatus). The syringe was connected to
the probe via polypropylene tubing. Solutions were delivered at a rate
of 25 μl/min. The length of the polypropylene tubing (150 or 180 cm)
resulted in an approximate delay of 20 min between initiation of
dialysis and when the solution in the syringe reached the probe.
Each dialysis study proceeded in the following order: a dialysis
probe was inserted unilaterally into one MT and the animal was given
30 min to stabilize; predialysis data were collected for 30 min; mCSF
was dialyzed for 60 min (hour 1); antagonist solution was dialyzed for
60 min (hour 2); and mCSF was dialyzed for 60 min (hour 3). In timecontrol studies, mCSF was dialyzed during hour 2. The dialysate
(effluent flow from the probe after solute exchange at the probe tip)
was collected at the end of each hour of dialysis in modified cryotubes,
aliquoted, and then frozen at −80°C for later analysis of
neurochemical content.
The following antagonists were used: ATR (Sigma-Aldrich, St.
Louis, MO), a nonselective mACh receptor antagonist; Spantide I (SPA,
U.S. Biological), an NK1 receptor antagonist; and MDL (Santa Cruz
Biotechnology, Santa Cruz, CA), a 5-HT2 receptor antagonist with
greater selectivity for the 5-HT2A receptor over the 5-HT2C receptor.
The following groups of animals were studied (goat numbers listed
according to the inset table in Fig. 1), differing only in the solution
dialyzed during hour 2 and day/night condition: Group 1, day 0.5 mM
MDL in 1.25% DMSO (n = 6, goats 1, 2, 3, 7, 8, and 10); Group 2,
day double cocktail (5 mM ATR and 267 μM SPA, n = 5, goats 1 and
7–10); Group 3, day triple cocktail (5 mM ATR, 500 μM SPA, and 0.5
mM MDL in 1.25% DMSO, n = 6, goats 2–6 and 11); and Group 4,
night triple cocktail (5 mM ATR, 500 μM SPA, and 0.5 mM MDL in
1.25% DMSO, n = 6, goats 2–6 and 11). Goats 12 and 13 were
studied, but their data were not included in group means or statistical
analyses. In general, daytime dialysis studies were completed between
9:00 A.M. and 2:00 P.M., whereas night studies were completed
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between 8:00 P.M. and 2:00 A.M. For any individual animal, ≥36 h
separated all studies.

Fig. 1. Microtubule (MT) placement (dialysis site) of each goat studied, excluding
goats in time-control studies. Sections are taken from the goat brainstem atlas (7)
and, for simplicity, MT placements are illustrated on three representative sections
only. Red circle indicates approximate location of the goat pre-Bötzinger Complex
(preBötC). Distance rostral from obex is indicated above each section. Circled numbers
represent each goat studied and the left/right placement of the MTs in which studies
were carried out. The corresponding N-methyl-d-aspartic acid (NMDA) injection (100
mM, 500 nl) response for each dialysis site, expressed as a percent of control, is also
indicated (inset table, blank entries indicate sides not included in analysis). Gray
shading (inset table) indicates animals anecdotally mentioned in the discussion but
excluded from group means and statistical analyses. Tissue from goat 11 was not
usable for Nissl staining and is not represented on the sections.

Mock CSF and N-methyl-d-aspartic acid injections.
Because application of glutamate receptor agonists to the
preBötC elicits a tachypneic ventilatory response,20,24,37,47 functional
assays utilizing injections of mCSF and a glutamate receptor agonist
into the MTs were performed to approximate MT placement relative to
the preBötC. The injection tube was inserted only up to the distal end
of the MT to avoid tissue damage. In these injection studies, breathing
was measured as described above. After collection of control data (30
min), mCSF or N-methyl-d-aspartic acid (NMDA, 100 mM) was
unilaterally injected (500 nl) into an MT. Injections were repeated on
the contralateral MT after breathing returned to baseline levels.
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Neurochemical analysis.
Neurochemical analyses were performed by a core assay
laboratory using methods identical to those used by Muere et al.25
These protocols are thus quoted from Muere et al.:25 “Glycine
[glutamine, (GLN)] and γ-aminobutyric acid (GABA) were measured by
reverse-phase high-performance liquid chromatography with
fluorescent detection using the following parameters: Waters Resolve
C18 column (150 × 3.9), a fluorescent detector with excitation at 229
nm and emission at 470 nm, β-alanine internal standard, and ophthaldialdehyde derivitization. For detection and measurement of 5HT, electrochemical detection with the same type of column was used,
but with a potential setting of 0.6 volts vs. Ag/AgCl reference electrode
and a N-methylserotonin internal standard. . . . A commercially
available immunoassay (Assay Designs 900-018, range 9.76–10,000
pg/ml) was used to measure SP via a microplate reader at 405 nm.”

Data analysis.
Inspiratory flow was calibrated at the end of all experiments and
data were analyzed as per past studies.25–27 Breath-by-breath analysis
of ventilatory data was carried out using custom-made programs. For
night studies, EEG and EOG activity was used to visually score each
breath according to the awake, rapid-eye-movement (REM), or NREM
sleep states. Scoring was performed by the same investigator for all
studies. Although REM was frequently observed, there were not
enough data for ventilatory analysis during the REM state.
As in past reports,26,27 we compared data from this investigation
to established time-control studies25 in which mCSF was dialyzed in all
3 h. The present studies were carried out under the same conditions
using identical methodologies as those in time-control studies.
Accordingly, we utilized these control data for two important reasons:
1) to minimize the number of goats used because repeating control
experiments may violate policies regarding using the smallest number
of animals to address scientific questions; and 2) we believe that direct
comparisons between time-control data and data from the studies
herein are necessary for interpretation and for framing results in
context with previous findings.
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All ventilatory data were binned in 15-min bins. Two-way
repeated-measures (RM) ANOVAs (one-factor repetition, group and
time/bin as factors, Holm-Sidak test post hoc when appropriate) were
performed for each ventilatory parameter. We thus used the P value of
the interaction term from the results of two-way RM ANOVAs to
determine whether the effect on breathing over time of antagonist
dialysis was significantly different from that of time-control studies.
When the P value of the interaction term was significant, we report
results of the post hoc test. To minimize noise, we limited the period of
analysis to the last nine bins of the study [i.e., the last 15-min bin in
hour 1 (bin 1), the four bins in hour 2 (bins 2–5), and the four bins in
hour 3 (bins 6–9)]. For night studies, two-way RM ANOVAs (two-factor
repetition, state and time/bin as factors, Holm-Sidak post hoc test
when appropriate) were also performed to determine whether there
were state-dependent effects of antagonist dialysis on breathing. One
animal did not have sufficient NREM sleep in hour 3 and was excluded
from analysis by the statistical software; thus for ventilatory variables,
the sample size for night studies was five.
As with the ventilatory data, for each group, two-way RM
ANOVAs (one-factor repetition, group and hour as factors, Holm-Sidak
test post hoc when appropriate) were performed for each
neurochemical. We used the P value of the interaction term from the
results of two-way RM ANOVAs to determine whether the effect on
effluent neurochemical concentration over time of antagonist dialysis
was significantly different from that of time-control studies. For night
triple-cocktail studies, one-way RM ANOVAs (Holm-Sidak test post hoc
when appropriate) were performed because time-control studies were
not conducted at night. When the P value of the interaction term or
one-way RM ANOVA was significant, we report results of the post hoc
test.
For any animal, data from replicate studies were averaged
before inclusion in group comparisons. All statistical analyses were
performed using SigmaPlot (version 12.0 or 12.5) and all results are
presented as means ± SE; values of P < 0.05 were considered
statistically significant.
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Histological analysis.
To determine MT placement, animals were sedated with
ketamine (2.3 ml, 100 mg/ml, iv), cerebral circulation was isolated,
and the goat was killed via injection of 10.0 ml (iv) of B-euthanasia.
The cranial vasculature was perfused with PBS via a catheter placed in
a carotid artery, followed by perfusion with 4% paraformaldehyde in
PBS. The brainstem was harvested and processed for sectioning and
Nissl-staining. Nissl-stained images were captured (scanned at 4,000
dots per inch; Nikon Super Coolscan 9000) and MT placements were
approximated using Metamorph software. Because the MT was
inserted from the dorsal surface, the distal extent of the MT tract from
the dorsal surface was considered to be the dorsal coordinate of MT
placement; the center of this tract was considered to be the mediallateral coordinate. The rostral-caudal coordinate relative to obex was
determined according to the tissue section on which the distal tip of
the MT tract was identified.

Results
Histological assessment and NMDA injection responses.
The preBötC in the goat is approximately 2.5–3.5 mm rostral
from obex, 4.0–5.0 mm lateral from the midline, and 4.0–6.0 mm
from the dorsal surface of the medulla, ventral to nucleus
ambiguous.20,47 Figure 1 is a simplified illustration of the MT
placements of the goats studied herein (excluding those in timecontrol studies) and their respective responses to NMDA injections
(100 mM, 500 nl, Fig. 1 inset table), which has previously been used
as a physiological marker of the preBötC.26,27 Goats 12 and 13 (gray
shading, Fig. 1 inset table) are discussed here as examples of animals
with unusual respiratory responses to cocktail dialysis (see Fig. 10 and
discussion) but their data were excluded from group means and
statistical analyses. In all of our microdialysis studies, there has been
variation in MT placement and the corresponding NMDA responses.26,27
In the present study, 11 of the 16 analyzed dialysis sites in Fig. 1
showed breathing frequency responses to NMDA injection of 15% or
more, suggesting that the MT was within the preBötC region.26,27 At
five sites there was no or minimal response to NMDA injection and
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histological assessment suggested that the MTs were outside the
targeted preBötC region. Because the injection tube was inserted only
up to the distal end of the MT, a lack of response to NMDA was likely
due to an extended distance between the injection site and the
preBötC. However, during dialysis, the membrane tip of the probe
extends 2 mm beyond the distal end of the MT, thus the diffusion
distance of dialyzed antagonists was likely not identical to that of
injected NMDA. Nevertheless, in this and our previous studies,25–27 the
concentration of neuromodulators (specifically, SP) in the effluent
mCSF has been remarkably consistent, irrespective of the NMDA
response and histological identification of MT placement. Thus we have
not excluded data from goats in which there was no or minimal
response to NMDA. Finally, due to variation in the NMDA response and
histological identification of MT placement, we refer to observed effects
within the VRC and not specifically to the preBötC.

Fig. 10. Examples of an abnormal respiratory response to daytime dialysis of a triple
cocktail of antagonists (5 mM ATR, 500 μM SPA, and 0.5 mM MDL). These animals
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were not included in either the group means or statistical analyses. A: minute volume
(VI, liters/min); B: frequency (F, breaths/min); C: tidal volume (VT, liters/breath).
Diamonds (goat 12) and circles (goat 13) represent two different animals (see Fig. 1).
The first data point represents the last 15-min bin of hour 1. Closed symbols and bar
indicate period of cocktail dialysis; open symbols indicate mCSF dialysis.

Blockade of 5-HT2A receptors in the VRC has modest
effects on breathing and neuromodulator concentration.
Comparisons between time-control studies (n = 7) and those of
0.5 mM MDL dialysis (n = 6) found a modestly significant interaction
effect only for VI (P = 0.046, Fig. 2A), and for which post hoc analysis
indicated a significant difference (P < 0.05) between groups in the
third bin of hour 2. There were no significant interaction effects for any
other ventilatory parameter (≥0.160, Fig. 2, B and C). Dialysis of MDL
did not significantly affect the effluent concentration of any
neuromodulator measured (P ≥ 0.062, Fig. 3, A–E) relative to the
time-control studies.

Fig. 2. Dialysis of 0.5 mM of the antagonist MDL 11939 (MDL) (n = 6) in the ventral
respiratory column (VRC) had no significant effect (P ≥ 0.160) on frequency (F,
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breaths/min, B) or tidal volume (VT, liters/breath, C) relative to time-control studies (n
= 7). However, MDL had a modestly significant effect on minute ventilation (VI,
liters/min, P = 0.046, A). The first data point represents the last 15-min bin of hour 1.
Closed symbols and bar indicate period of MDL dialysis; open symbols indicate mock
cerebral spinal fluid (mCSF) dialysis. F and P indicate values for interaction term from
two-way repeated-measures (RM) ANOVA. #P ≤ 0.05 between groups per post hoc
analysis.

Fig. 3. Dialysis of 0.5 mM MDL (n = 6) in the VRC had no significant effect (P ≥
0.062) on the effluent concentrations of serotonin (5-HT, A), glutamine (GLN, B),
substance P (SP, C), glycine (D), or GABA (E) relative to time-control studies (n = 7).
The x-axes indicate hour of dialysis; y-axes indicate effluent neurochemical
concentration. Filled bars indicate dialysis of MDL; open bars indicate dialysis of mCSF.
Bars on the left are data from time-control studies; bars on the right are data from
MDL studies. F and P indicate values for interaction term from two-way RM ANOVA.

Effects on breathing and neuromodulator concentration
of blockade of mACh, NK1, and 5-HT2A receptors.
Combined blockade of mACh receptors and NK1 receptors in the
VRC via dialysis of a double cocktail of antagonists (5 mM ATR and 267
μM SPA, n = 5) had no significant effect on any ventilatory parameter
(P ≥ 0.084, Fig. 4, A–C) relative to the time-control studies. Double
blockade of mACh receptors and NK1 receptors significantly increased
the effluent concentration of SP (P < 0.001, Fig. 5C) when it was
significantly elevated during hours 2 and 3 compared with both
baseline and time-control values (P < 0.001) as determined by post
hoc analysis. The double cocktail had no significant effect on the levels
of any other neuromodulator (P ≥ 0.058; Fig. 5, A, B, D, and E).
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Fig. 4. Dialysis of a double cocktail of antagonists [5 mM atropine (ATR), 267 μM
Spantide I (SPA, an NK1 receptor antagonist), n = 5] in the VRC had no significant
effect (P ≥ 0.084) on any respiratory parameter relative to time-control studies (n =
7). A: minute ventilation (VI, liters/min); B: frequency (F, breaths/min); C: tidal
volume (VT, liters/breath). The first data point represents the last 15-min bin of hour
1. Closed symbols and bar indicate period of cocktail dialysis; open symbols indicate
mCSF dialysis. F and P indicate values for interaction term from two-way repeatedmeasures ANOVA.

Fig. 5. Dialysis of a double cocktail of antagonists (5 mM ATR, 267 μM SPA, n = 5) in
the VRC significantly increased the effluent SP concentration (P < 0.001, C) relative to
time-control studies (n = 7) but had no significant effect (P > 0.05) on serotonin (5Journal of Applied Physiology, Vol 119, No. 3 (August 1, 2015): pg. 308-320. DOI. This article is © American Physiological
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HT, A), glutamine (GLN, B), glycine (D), or GABA (E), although the effect on GABA
was close to significant. The x-axes indicate hour of dialysis; y-axes indicate effluent
neurochemical concentration. Filled bars indicate dialysis of cocktail; open bars
indicate dialysis of mCSF. Bars on the left are data from time-control studies; bars on
the right are data from cocktail studies. F and P indicate values for interaction term
from two-way RM ANOVA. **P ≤ 0.001 vs. hour 1; ††P ≤ 0.001 vs. hour 2; ##P ≤
0.001 vs. time-control value per post hoc analysis.

Similarly, blockade of receptors of mACh, NK1, and 5-HT2A with
a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, and 0.5 mM
MDL, n = 6) during the day had no significant effect on any respiratory
variable (P ≥ 0.509, Fig. 6, A–C). However, there was a significant
increase in effluent SP concentration (P < 0.001, Fig. 7C). As with the
double cocktail, post hoc analysis showed that SP remained
significantly elevated during hours 2 and 3 with triple cocktail dialysis
compared with both baseline and time-control values (P ≤ 0.001).
There were significant decreases in effluent glutamine (P = 0.010, Fig.
7B) and GABA (P = 0.045, Fig. 7E) concentrations. Post hoc analysis
indicated that glutamine decreased over time with triple cocktail
dialysis (P ≤ 0.001) and was significantly different than time-control
values in hour 3 (P < 0.05). Effluent GABA concentration also
decreased over time (P ≤ 0.001) as revealed by post hoc testing,
however, there was also a significant difference in baseline GABA
concentration between the cocktail and time-control groups (P <
0.05). Blockade with a triple cocktail did not significantly affect the
effluent concentrations of 5-HT or glycine (P ≥ 0.136, Fig. 7, A and D).
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Fig. 6. Daytime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA,
and 0.5 mM MDL, n = 6) in the VRC had no significant effect (P ≥ 0.509) on any
respiratory parameter relative to time-control studies (n = 7). A: minute ventilation
(VI, liters/min); B: frequency (F, breaths/min); C: tidal volume (VT, liters/breath). The
first data point represents the last 15-min bin of hour 1. Closed symbols and bar
indicate period of cocktail dialysis; open symbols indicate mCSF dialysis. F and P
indicate values for interaction term from two-way RM ANOVA.
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Fig. 7. Daytime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA,
and 0.5 mM MDL, n = 6) in the VRC significantly increased the effluent concentration
of substance P (SP, P < 0.001, C) and significantly decreased (P ≤ 0.045) the effluent
concentrations of glutamine (GLN, B) and GABA (E); cocktail dialysis had no significant
effect (P ≥ 0.136) on serotonin (5-HT, A) or glycine (GLY, D) concentration. The xaxes indicate hour of dialysis; y-axes indicate effluent neurochemical concentration.
Filled bars indicate dialysis of cocktail; open bars indicate dialysis of mCSF. Bars on
the left are data from time-control studies; bars on the right are data from cocktail
studies. F and P indicate values for interaction term from two-way repeated-measures
ANOVA. **P ≤ 0.001 vs. hour 1; ††P ≤ 0.001 vs. hour 2; #P < 0.05; ##P ≤ 0.001 vs.
time-control value per post hoc analysis.

Nighttime effects on breathing and neuromodulator
concentration of blockade of mACh, NK1, and 5-HT2A
receptors.
Dialysis of the same triple cocktail of antagonists (5 mM ATR,
500 μM SPA, and 0.5 mM MDL, n = 5 for ventilatory data, n = 6 for
neurochemical data) at night had no state-dependent effects on any
ventilatory variable (P ≥ 0.134, Fig. 8, A–C) as determined by the
interaction term for sleep state and time from two-way RM ANOVAs.
However, there were significant increases in effluent 5-HT (P = 0.040,
Fig. 9A) and SP (P < 0.001, Fig. 9C) concentrations, although post hoc
analysis of 5-HT data did not identify which hours were significantly
different. SP was significantly elevated during hours 2 and 3 (P <
0.001, post hoc). Triple-cocktail dialysis at night had no significant
effect on the effluent concentration of any of the three amino acids (P
≥ 0.210; Fig. 9, B, D, and E).
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Fig. 8. Nighttime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA,
and 0.5 mM MDL, n = 5) in the VRC did not have significant state-dependent effects
on any respiratory parameter (P ≥ 0.134). A: minute ventilation (VI, liters/min); B:
frequency (F, breaths/min); C: tidal volume (VT, liters/breath). Squares represent
breathing during non-rapid eye movement sleep; circles represent breathing during
wakefulness. The first data point represents the last 15-min bin of hour 1. Closed
symbols and bar indicate period of cocktail dialysis; open symbols indicate mCSF
dialysis. F and P indicate values for interaction term from two-way RM ANOVA.
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Fig. 9. Nighttime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA,
and 0.5 mM MDL, n = 6) in the VRC significantly increased the effluent concentrations
of serotonin (5-HT, P = 0.040, A) and substance P (SP, P < 0.001, C) while having no
significant effect (P ≥ 0.210) on glutamine (GLN, B), glycine (GLY, D), or GABA (E).
The x-axes indicate hour of dialysis; y-axes indicate effluent neurochemical
concentration. Filled bars indicate dialysis of cocktail; open bars indicate dialysis of
mCSF. F and P indicate values from one-way RM ANOVA. **P ≤ 0.001 vs. hour 1; †P
≤ 0.05 vs. hour 2 per post hoc analysis.

Animals excluded from statistical analyses.
In two additional animals, day (Fig. 10) and night (data not
shown) dialysis studies of the same triple cocktail of antagonists were
completed. These goats were not included in either the group means
or statistical analyses because they had an abnormally strong
response to the cocktail, characterized by a large, sustained increase
in VI (Fig. 10A) driven by an increase in breathing frequency (Fig.
10B). VT did not appear to be much affected by triple cocktail dialysis
(Fig. 10C).

Discussion
No effect of combined receptor blockade on breathing.
Many studies have previously demonstrated the contributions to
breathing of muscarinic, NK1, and 5-HT receptors in various
models.3,5,11,16,17,28,32,34,35,42,46 However, the large array of excitatory
and inhibitory inputs to the respiratory network10 suggests that
neuromodulators likely act in concert to regulate breathing.
Furthermore, their effects might not necessarily be additive, and the
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effects of one modulator may be dependent on the presence or
absence of another modulator.9 The importance of understanding the
effects of multiple receptor types on breathing has also been pointed
out by Doi and Ramirez,10 who noted that “future studies need to
address the combinatory effects of different neuromodulators. For
example, by simultaneously blocking muscarinic, nicotinic, 5-HT2 and
NK1 receptors. . . . to learn whether the contribution of each
neuromodulator is cumulative and whether the drive of all
neuromodulators is necessary for maintaining baseline frequency.”
We hypothesized that simultaneous blockade of muscarinic,
NK1, and 5-HT2A receptors would not alter breathing, but it would alter
multiple neuromodulators. The hypothesis was confirmed, because we
found that combined blockade of receptors of mACh, NK1, and 5-HT2A
did not significantly affect breathing, but it consistently increased the
effluent concentrations of SP while significantly decreasing or tending
to decrease the effluent concentrations of GABA.
We previously found that unilateral dialysis into the VRC of 50
mM ATR increased 5-HT and SP in the effluent mCSF,25 which we
postulate may have overcompensated for a reduction in muscarinic
excitation to thereby increase breathing. In that study, the inhibitory
neuromodulators GABA and glycine also increased, possibly in
response to overcompensation in 5-HT and SP release. Importantly,
these changes in neuromodulators occurred specifically at the site of
dialysis, not in the contralateral VRC, indicating that neuromodulator
interdependence likely occurs locally and not globally.25 In subsequent
studies, including the present, we unilaterally dialyzed a lower
concentration of ATR,26 and antagonists to NK127 and 5-HT2A receptors
individually, and we also dialyzed these excitatory receptor antagonists
simultaneously. Overall, none of these treatments altered breathing,
but SP consistently increased, and GABA either tended to decrease in
the dialysate, or it did so significantly. In the present study, the
changes in SP and GABA may have compensated for the presumed
reduction in neuronal excitation with blockade of 5-HT2A, NK1 and
muscarinic receptors, resulting in no change in breathing.
Although neuromodulator interdependence appears to be
mediated locally, other potential contributing mechanisms to maintain
stable breathing could be through anatomical connectivity with the
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contralateral preBötC,41 or through reflex compensation independent of
changes in neuromodulators in the contralateral preBötC. Indeed, we
have shown that bilateral neurotoxic destruction of the preBötC in
awake goats results in terminal apnea.47 However, unilateral
destruction did not induce apnea, but it did induce hypoventilation for
several hours. Additionally, St-Jacques and St-John38 found in
decerebrate, vagotomized rats that attenuation of preBötC activity
with unilateral injection of muscimol, the inhibitory GABA agonist,
resulted in several minutes of respiratory apnea. Moreover, in
anesthetized mice, unilateral injections into the preBötC of an
excitatory receptor antagonist or a cocktail of antagonists caused a
significant decrease in respiratory frequency.11 These examples of
hypoventilation/apnea resulting from unilateral perturbations are in
contrast to our findings that unilateral dialysis of antagonists to
excitatory receptors appears to elicit a rapid and precise response to
maintain stable breathing. Accordingly, our unilateral dialysis studies
demonstrate an important fundamental characteristic of the
respiratory control network: that is, its ability to compensate for
fluctuations in excitatory input. Furthermore, neuromodulator
interdependence does not appear to be unique to the preBötC region
because we found changes in neuromodulators irrespective of the site
of dialysis in the VRC (Fig. 1). Moreover, in previous studies, we found
that dialysis of ATR into the pontine Kölliker-Fuse nucleus elicited
increases in SP comparable to ATR dialysis into the VRC (unpublished
data). Finally, we speculate that neuromodulator interdependence may
not be unique to the respiratory control network nor even to
mammals, because it likely occurs in other central-pattern generators
such as those controlling mastication, locomotion, and the crustacean
stomatogastric ganglion and cardiac ganglia, which generate motor
patterns.4,9,23,31

Potential mechanisms stabilizing breathing in the face
of ubiquitous neuromodulation or attenuation of
multiple neuromodulation.
In a recent overview of neuromodulation of neuronal circuits,
Dr. Eve Marder23 addressed two pertinent questions. First, why don't
neural circuits important for behavior become overmodulated? And
second, what mechanisms might protect against overmodulation? She
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thereby proposed five potential stability mechanisms: 1) modulators
that coordinately act on opposing processes by acting on both inward
and outward currents; 2) voltage-dependence of modulator actions; 3)
convergence of many modulators onto the same voltage-dependent
current (or, as we additionally suggest, convergence onto the same
second-messenger pathway); 4) saturation of postsynaptic action; and
5) modulators act coordinately on multiple targets to keep systems
functionally matched (i.e., coordinated modulation of the central
pattern generator, the neuromuscular junction, and muscle activity).23
One or more of these protective mechanisms against overmodulation
may also be protective against the reverse situation of excessive
attenuation of excitatory neuromodulator receptor activity due to
antagonist dialysis. For example, receptors targeted by our antagonist
cocktails couple to G protein-coupled receptors of the Gq/11 subtype,10
thereby converging on the same second-messenger system, the
phospholipase C (PLC) pathway. This commonality might explain why
5 mM ATR,26 SPA,27 and MDL each had the same effect on breathing
(i.e., no effect) when dialyzed individually or in combination. It is also
possible that simultaneous blockade of mACh, NK1, and 5-HT2A
receptors is still not enough to significantly depress activity in the PLC
pathway to a degree such that breathing is affected. This may be due
to the multitude of other receptors that couple to the Gq/11 subtype,10
such as the α-1 adrenergic and P2Y purinergic receptors,10,13 both of
which can modulate respiratory network activity.21,43
Alternatively, potentiation of signaling in parallel pathways
might partially account for the maintenance of breathing during
antagonist challenge. The most consistent finding in these and past
studies is an antagonist-induced increase in effluent SP
concentration.25–27 It is possible that the excess SP may be binding and
activating NK2 and NK3 receptors, negating the antagonist effects on
NK1 receptors.6,33,39 NK2 and NK3 receptors have previously been
shown to provide excitatory modulation in the rabbit preBötC, likely
through activation by SP,2 which can also exert effects through these
receptors.6 Another example is the 5-HT4A receptor, which is coupled
to the Gs G protein-coupled receptor subtype. Activation of this
receptor leads to stimulation of adenylyl cyclase, the protein kinase A
pathway, and inactivation of potassium channels.10 The 5-HT4A
receptor is known to be expressed in the preBötC and has excitatory
respiratory effects capable of reversing fentanyl-induced respiratory
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depression.22 Thus any 5-HT in the extracellular space, presumably
blocked from interacting with 5-HT2A receptors during MDL or cocktail
dialysis, may instead be acting on 5-HT4A receptors to stimulate
breathing without any necessary increases in 5-HT concentration. In
summary, the point we wish to emphasize is that there may be
adequate redundancy and multiplicity of excitatory inputs to the VRC,
such that blocking a subset of these receptors with double or triple
cocktails of antagonists would be insufficient to significantly decrease
breathing.
Finally, the most consistent effect on neuromodulator
concentration of cocktail dialysis was an increase in SP and a tendency
for GABA to decrease, although the changes in GABA were not all
significant. If NK1 receptors and 5-HT2A receptors are blocked, it is
possible that the decrease in effluent GABA concentration may have
offset reduced activation of excitatory receptors, preventing an
attenuation of breathing with cocktail dialysis. Due to involvement of
glutamine in the reuptake and recycling of GABA,1 the observed
decreases in glutamine we report may reflect decreases in GABA
release.

Additional neuromodulatory inputs with the potential
for compensation.
It is important to note that neuromodulators not measured
herein may have had effects that contributed to the maintenance of
breathing observed in the present studies. These neuromodulators
likely include orexin,8 histamine,10 ATP,13,15,21 prostaglandins,19 and
catecholamines.43 Evidence from past work shows that the modulatory
environment can reversibly affect the number and type of pacemaker
cells in a population of respiratory neurons,43 and that physiological
state (e.g., hypoxia) can influence the dependence of the respiratory
network on different modulators/pacemaker currents. Examples of
modulators that illustrate these points are norepinephrine (NE) and 5HT. In mouse brainstem slices containing the ventral respiratory
group,43 application of NE was found to increase fictive respiratory
frequency via the α-1 receptor. In addition to differentially modulating
burst shape and frequency of distinct pacemaker neurons, NE also
induced conditional expression of cadmium-sensitive pacemaker
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properties in what were originally nonpacemaker neurons.43
Conversely, pacemaker properties of cadmium-insensitive neurons are
instead dependent on 5-HT2A receptors.30 Whereas bursting in
cadmium-sensitive pacemakers is dependent on the nonspecific cation
current (ICAN), bursting properties in cadmium-insensitive pacemakers
depend on the persistent sodium current (INaP).14,29,45 Finally, during
hypoxia and subsequent gasping behavior, the respiratory network is
believed to reconfigure into one that is selectively dependent on
INaP.10,12,14,29 Thus subtle changes in (or complete blockade of) NE or 5HT may have altered the relative expression of these current types or
the dependence of the respiratory network on a given
modulator/current type. Reconfiguration of the network in this manner
during antagonist dialysis may partially account for the stability of
breathing.
A neuromodulator may also have different effects on breathing
depending on the modulatory/physiological state of the network, as
previously proposed by others.11 This concept has been recently
demonstrated by Zanella et al.49 In those studies, NE, which can act to
stabilize respiratory activity in reduced preparations,44 was found to
actually increase respiratory irregularity in vitro and in vivo,
specifically after exposure to acute intermittent hypoxia.49 Similarly,
prostaglandin E2 (PGE2) when applied at low concentrations has been
shown by Koch et al.19 to selectively increase sigh frequency, but not
eupneic frequency, although it increases both sigh and eupneic
frequency at higher concentrations. Using inhibitors of the INaP and
ICAN, the study further suggests that the contrasting effects of PGE2
concentration on distinct respiratory behaviors may be due to
differential modulation of INaP at low concentrations vs. ICAN at higher
concentrations. Thus the effect of a modulator is context-dependent,
and changes in the balance of excitatory and inhibitory modulators
may drastically alter the net output of a network. This phenomenon
has been previously demonstrated in other neural networks;
specifically, the cardiac sac motor pattern in the lobster, wherein the
effect of proctolin is dependent upon exposure of the network to redpigment-concentrating hormone.9
Relevant to the preceding discussion on modulatory
environment are findings on two goats that displayed large, sustained
increases in breathing frequency (+20 breaths/min) with dialysis of
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the triple cocktail of antagonists, both in the day (Fig. 10) and night
(data not shown), while awake and in NREM sleep. The responses of
these animals were clearly different from those of the rest of the
group; as such, they were excluded from group means and statistical
analysis. An interesting distinguishing feature common to these two
goats was a higher-than-average baseline breathing frequency (≥30
breaths/min). Daytime baseline levels of 5-HT and SP were within
normal range and changes in these neuromodulators with dialysis of
the triple cocktail were comparable to those of the rest of the group.
However, one animal had lower-than-average baseline levels of glycine
and GABA, which may have partially contributed to an overall higher
baseline breathing frequency. Although it is difficult to determine the
precise cause of the elevated baseline breathing, these observations
suggest that the response to receptor blockade may be dependent
upon the initial modulatory or physiological state of the animal.
Indeed, the dependence of a drug effect on baseline respiratory
activity has been demonstrated in other studies. In particular, studies
in anesthetized mice found that hemilateral injection of a NK1 receptor
antagonist (RP67580) into the preBötC region significantly decreased
respiratory frequency.11 However, the inhibitory effect of RP67580 was
significantly correlated with the baseline breathing frequency of the
animal: mice with lower starting frequencies showed a larger decrease
in frequency with NK1 receptor blockade.11 The same studies found
that when both α-1 NE and 5-HT2 receptors were blocked, the
inhibitory effect of RP67580 was further accentuated. The authors
therefore concluded that breathing depends on NK1 receptor activation
more so at low breathing frequencies or under conditions of reduced
excitatory transmission. The contrasting effects of receptor blockade
on breathing in these mouse studies (decrease) vs. our observations in
goats (increase) may be due to the use of anesthesia. Despite this
caveat, both models suggest that the effect of an antagonist on
breathing may depend on the respiratory/modulatory state of the
animal.
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Limitations.
Technical limitations and sample availability prevented
measurement of ACh/choline and thyrotropin-releasing hormone in the
present studies. The limitations of the use of dialysis in our animal
model to investigate the control of breathing have been discussed in
greater detail in previous publications;25,26 only a brief summary is
given here. First, the precise boundaries of the goat preBötC remain
unclear,20 rendering MT placement difficult in some animals. Second,
determination of the diffusion area of dialyzed substances can be
problematic. Accordingly, we cannot precisely identify the site affected
by NMDA injections or dialysis of antagonists, thus we believe it most
appropriate to state that our observed effects were within the VRC.
Third, the length of the infusion line connecting the syringe in the
dialysis pump to the probe (i.e., dead space in delivery) required ∼20
min for fresh solution to reach the probe, thus antagonist delivery
continued for 20 min into the third hour of mCSF dialysis. This dead
space in our delivery system likely explains why SP consistently
remained elevated during hour 3. Fourth, pertinent to our night
studies, we were unable to separate neurochemicals collected during
different sleep states. Additionally, sleep state-associated changes in
fractional interstitial volume48 have been previously reported, which
would affect both modulator and drug concentrations in the tissue.
Finally, repeated probe insertions in one MT may have caused potential
tissue damage around the site of dialysis.

Conclusion.
Combined unilateral blockade of mACh, NK1, and 5-HT2A
receptors in the goat VRC does not affect breathing. This lack of effect
may be due to a number of compensatory mechanisms, including
redundancy/multiplicity of excitatory inputs to the VRC, activation of
parallel signaling pathways, the contribution of other neuromodulators
not measured herein, the effects of changes in the modulatory milieu
on the number and type of pacemakers in the VRC, or alterations in
the dependence of the respiratory network on different
modulators/current types. Our data suggest that many interacting
systems may need to be substantially impaired for the emergence or
complete manifestation of respiratory deficits. If such is the case, it
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would be highly relevant to disease conditions in which multiple
modulator systems are affected. An example of such is Rett syndrome,
in which abnormalities in glutamate, GABA, brain-derived neurotrophic
factor, NE, and 5-HT have all been implicated in the respiratory
pathologies associated with the disorder.18 Our conclusions emphasize
the need to adopt a multiform approach in treating such conditions or
alleviating associated respiratory defects. Furthermore, anecdotal
evidence and the published work of others11 suggest that the
effectiveness of a treatment may be dependent on the initial
respiratory status of the patient.
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